|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-11-26
|
|
pubmed:abstractText |
To date, no data exist assessing the impact of either methadone or buprenorphine on adherence to highly active antiretroviral therapy (HAART) in the long term. This study was conducted in order to evaluate whether receiving take-home methadone and buprenorphine may ensure better adherence to HAART in individuals infected with human immunodeficiency virus (HIV) through injection drug use (IDU).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1360-0443
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1828-36
|
|
pubmed:meshHeading |
pubmed-meshheading:18778390-Adult,
pubmed-meshheading:18778390-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18778390-Buprenorphine,
pubmed-meshheading:18778390-Epidemiologic Studies,
pubmed-meshheading:18778390-Female,
pubmed-meshheading:18778390-HIV Infections,
pubmed-meshheading:18778390-Humans,
pubmed-meshheading:18778390-Male,
pubmed-meshheading:18778390-Methadone,
pubmed-meshheading:18778390-Narcotics,
pubmed-meshheading:18778390-Opioid-Related Disorders,
pubmed-meshheading:18778390-Patient Compliance
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
|
|
pubmed:affiliation |
Inserm U912 (SE4S), Marseille, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
